nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—kidney cancer	0.363	0.719	CbGaD
Perindopril—ABCB1—kidney cancer	0.142	0.282	CbGaD
Perindopril—ABCB1—Temsirolimus—kidney cancer	0.0508	0.225	CbGbCtD
Perindopril—ABCB1—Pazopanib—kidney cancer	0.0267	0.118	CbGbCtD
Perindopril—ABCB1—Dactinomycin—kidney cancer	0.0244	0.108	CbGbCtD
Perindopril—ABCB1—Gemcitabine—kidney cancer	0.0193	0.0856	CbGbCtD
Perindopril—ABCB1—Erlotinib—kidney cancer	0.019	0.0845	CbGbCtD
Perindopril—ACE—renal artery—kidney cancer	0.0187	0.36	CbGeAlD
Perindopril—ABCB1—Paclitaxel—kidney cancer	0.0174	0.0773	CbGbCtD
Perindopril—ABCB1—Sorafenib—kidney cancer	0.0155	0.0687	CbGbCtD
Perindopril—ABCB1—Vinblastine—kidney cancer	0.0153	0.0678	CbGbCtD
Perindopril—ABCB1—Vincristine—kidney cancer	0.015	0.0667	CbGbCtD
Perindopril—ABCB1—Sunitinib—kidney cancer	0.0125	0.0557	CbGbCtD
Perindopril—ABCB1—Doxorubicin—kidney cancer	0.00939	0.0417	CbGbCtD
Perindopril—ACE—nephron—kidney cancer	0.00652	0.126	CbGeAlD
Perindopril—ACE—urine—kidney cancer	0.00523	0.101	CbGeAlD
Perindopril—SLC15A1—nephron tubule—kidney cancer	0.00196	0.0379	CbGeAlD
Perindopril—SLC15A1—renal system—kidney cancer	0.00179	0.0344	CbGeAlD
Perindopril—SLC15A1—kidney—kidney cancer	0.00173	0.0333	CbGeAlD
Perindopril—ACE—nephron tubule—kidney cancer	0.00141	0.0271	CbGeAlD
Perindopril—ACE—renal system—kidney cancer	0.00128	0.0247	CbGeAlD
Perindopril—ACE—kidney—kidney cancer	0.00124	0.0239	CbGeAlD
Perindopril—SLC15A2—nephron tubule—kidney cancer	0.00123	0.0237	CbGeAlD
Perindopril—ACE—cortex of kidney—kidney cancer	0.00121	0.0232	CbGeAlD
Perindopril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—kidney cancer	0.00117	0.108	CbGpPWpGaD
Perindopril—ACE—gonad—kidney cancer	0.00115	0.0221	CbGeAlD
Perindopril—ACE—cardiac atrium—kidney cancer	0.00115	0.0221	CbGeAlD
Perindopril—SLC15A2—renal system—kidney cancer	0.00112	0.0215	CbGeAlD
Perindopril—SLC15A2—kidney—kidney cancer	0.00108	0.0208	CbGeAlD
Perindopril—SLC15A2—cortex of kidney—kidney cancer	0.00105	0.0203	CbGeAlD
Perindopril—BCHE—nephron tubule—kidney cancer	0.00104	0.02	CbGeAlD
Perindopril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—kidney cancer	0.00085	0.0787	CbGpPWpGaD
Perindopril—BCHE—cardiac atrium—kidney cancer	0.000847	0.0163	CbGeAlD
Perindopril—Ramipril—BCHE—kidney cancer	0.000643	0.588	CrCbGaD
Perindopril—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.000627	0.0581	CbGpPWpGaD
Perindopril—ABCB1—nephron tubule—kidney cancer	0.000496	0.00955	CbGeAlD
Perindopril—ABCB1—renal system—kidney cancer	0.000451	0.00869	CbGeAlD
Perindopril—ABCB1—kidney—kidney cancer	0.000436	0.0084	CbGeAlD
Perindopril—ABCB1—cortex of kidney—kidney cancer	0.000424	0.00818	CbGeAlD
Perindopril—ABCB1—gonad—kidney cancer	0.000404	0.00779	CbGeAlD
Perindopril—BCHE—Synthesis, secretion, and deacylation of Ghrelin—ACHE—kidney cancer	0.000343	0.0318	CbGpPWpGaD
Perindopril—BCHE—Synthesis of PC—ACHE—kidney cancer	0.000314	0.0291	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—MME—kidney cancer	0.000308	0.0285	CbGpPWpGaD
Perindopril—Cilazapril—ABCB1—kidney cancer	0.00026	0.238	CrCbGaD
Perindopril—ACE—Peptide hormone metabolism—ACHE—kidney cancer	0.000236	0.0219	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—PAX6—kidney cancer	0.000224	0.0208	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—CTSD—kidney cancer	0.000223	0.0207	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—BCHE—kidney cancer	0.000206	0.019	CbGpPWpGaD
Perindopril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000197	0.0182	CbGpPWpGaD
Perindopril—Enalapril—ABCB1—kidney cancer	0.000191	0.174	CrCbGaD
Perindopril—BCHE—Irinotecan Pathway—APC—kidney cancer	0.00019	0.0176	CbGpPWpGaD
Perindopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000183	0.0169	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HARS—kidney cancer	0.000152	0.0141	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—MME—kidney cancer	0.000123	0.0114	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—EIF5B—kidney cancer	0.000118	0.0109	CbGpPWpGaD
Perindopril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000116	0.0107	CbGpPWpGaD
Perindopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000108	0.00997	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—POMC—kidney cancer	0.000106	0.00984	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CUL7—kidney cancer	0.000105	0.00971	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—HSPA9—kidney cancer	0.0001	0.00927	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	9.82e-05	0.0091	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—ACHE—kidney cancer	9.47e-05	0.00877	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	9.23e-05	0.00855	CbGpPWpGaD
Perindopril—BCHE—Glycerophospholipid biosynthesis—ACHE—kidney cancer	9.21e-05	0.00853	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	9.11e-05	0.00844	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—PAX6—kidney cancer	9.01e-05	0.00835	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—CTSD—kidney cancer	8.96e-05	0.0083	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—LRRK2—kidney cancer	8.74e-05	0.0081	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—RYR1—kidney cancer	8.69e-05	0.00805	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	8.58e-05	0.00795	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—MUC4—kidney cancer	8.15e-05	0.00755	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—RYR1—kidney cancer	8.06e-05	0.00747	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	7.85e-05	0.00727	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—ST3GAL2—kidney cancer	7.76e-05	0.00719	CbGpPWpGaD
Perindopril—Nausea—Erlotinib—kidney cancer	7.69e-05	0.000374	CcSEcCtD
Perindopril—Alopecia—Capecitabine—kidney cancer	7.68e-05	0.000373	CcSEcCtD
Perindopril—Dry mouth—Paclitaxel—kidney cancer	7.68e-05	0.000373	CcSEcCtD
Perindopril—Mood swings—Doxorubicin—kidney cancer	7.67e-05	0.000373	CcSEcCtD
Perindopril—Diarrhoea—Sunitinib—kidney cancer	7.67e-05	0.000373	CcSEcCtD
Perindopril—Mental disorder—Capecitabine—kidney cancer	7.62e-05	0.00037	CcSEcCtD
Perindopril—Asthenia—Dactinomycin—kidney cancer	7.61e-05	0.00037	CcSEcCtD
Perindopril—Confusional state—Paclitaxel—kidney cancer	7.59e-05	0.000369	CcSEcCtD
Perindopril—Blood creatinine increased—Doxorubicin—kidney cancer	7.59e-05	0.000369	CcSEcCtD
Perindopril—ACE—Peptide hormone metabolism—CTNNB1—kidney cancer	7.58e-05	0.00702	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—EEF2—kidney cancer	7.58e-05	0.00702	CbGpPWpGaD
Perindopril—Erythema—Capecitabine—kidney cancer	7.57e-05	0.000368	CcSEcCtD
Perindopril—Malnutrition—Capecitabine—kidney cancer	7.57e-05	0.000368	CcSEcCtD
Perindopril—Oedema—Paclitaxel—kidney cancer	7.53e-05	0.000366	CcSEcCtD
Perindopril—Anaphylactic shock—Paclitaxel—kidney cancer	7.53e-05	0.000366	CcSEcCtD
Perindopril—Body temperature increased—Vincristine—kidney cancer	7.49e-05	0.000364	CcSEcCtD
Perindopril—Abdominal pain—Vincristine—kidney cancer	7.49e-05	0.000364	CcSEcCtD
Perindopril—Flatulence—Capecitabine—kidney cancer	7.46e-05	0.000363	CcSEcCtD
Perindopril—Dry skin—Doxorubicin—kidney cancer	7.43e-05	0.000361	CcSEcCtD
Perindopril—Dysgeusia—Capecitabine—kidney cancer	7.41e-05	0.00036	CcSEcCtD
Perindopril—Dizziness—Sunitinib—kidney cancer	7.41e-05	0.00036	CcSEcCtD
Perindopril—Feeling abnormal—Gemcitabine—kidney cancer	7.41e-05	0.00036	CcSEcCtD
Perindopril—Shock—Paclitaxel—kidney cancer	7.4e-05	0.00036	CcSEcCtD
Perindopril—Vomiting—Sorafenib—kidney cancer	7.4e-05	0.00036	CcSEcCtD
Perindopril—Abdominal pain upper—Doxorubicin—kidney cancer	7.4e-05	0.00036	CcSEcCtD
Perindopril—Orthostatic hypotension—Doxorubicin—kidney cancer	7.4e-05	0.00036	CcSEcCtD
Perindopril—Nervous system disorder—Paclitaxel—kidney cancer	7.38e-05	0.000359	CcSEcCtD
Perindopril—Thrombocytopenia—Paclitaxel—kidney cancer	7.37e-05	0.000358	CcSEcCtD
Perindopril—Tachycardia—Paclitaxel—kidney cancer	7.35e-05	0.000357	CcSEcCtD
Perindopril—Rash—Sorafenib—kidney cancer	7.34e-05	0.000357	CcSEcCtD
Perindopril—Dermatitis—Sorafenib—kidney cancer	7.33e-05	0.000357	CcSEcCtD
Perindopril—Back pain—Capecitabine—kidney cancer	7.32e-05	0.000356	CcSEcCtD
Perindopril—Breast disorder—Doxorubicin—kidney cancer	7.32e-05	0.000356	CcSEcCtD
Perindopril—Skin disorder—Paclitaxel—kidney cancer	7.31e-05	0.000355	CcSEcCtD
Perindopril—Headache—Sorafenib—kidney cancer	7.29e-05	0.000355	CcSEcCtD
Perindopril—Muscle spasms—Capecitabine—kidney cancer	7.28e-05	0.000354	CcSEcCtD
Perindopril—Hyperhidrosis—Paclitaxel—kidney cancer	7.28e-05	0.000354	CcSEcCtD
Perindopril—Diarrhoea—Dactinomycin—kidney cancer	7.26e-05	0.000353	CcSEcCtD
Perindopril—Nasopharyngitis—Doxorubicin—kidney cancer	7.24e-05	0.000352	CcSEcCtD
Perindopril—Anorexia—Paclitaxel—kidney cancer	7.17e-05	0.000349	CcSEcCtD
Perindopril—Muscular weakness—Doxorubicin—kidney cancer	7.14e-05	0.000347	CcSEcCtD
Perindopril—Vomiting—Sunitinib—kidney cancer	7.12e-05	0.000346	CcSEcCtD
Perindopril—Body temperature increased—Gemcitabine—kidney cancer	7.11e-05	0.000345	CcSEcCtD
Perindopril—Tremor—Capecitabine—kidney cancer	7.09e-05	0.000345	CcSEcCtD
Perindopril—Rash—Sunitinib—kidney cancer	7.06e-05	0.000343	CcSEcCtD
Perindopril—Dermatitis—Sunitinib—kidney cancer	7.06e-05	0.000343	CcSEcCtD
Perindopril—Hypotension—Paclitaxel—kidney cancer	7.03e-05	0.000342	CcSEcCtD
Perindopril—Ill-defined disorder—Capecitabine—kidney cancer	7.02e-05	0.000341	CcSEcCtD
Perindopril—Headache—Sunitinib—kidney cancer	7.02e-05	0.000341	CcSEcCtD
Perindopril—Asthma—Doxorubicin—kidney cancer	7e-05	0.00034	CcSEcCtD
Perindopril—Anaemia—Capecitabine—kidney cancer	6.99e-05	0.00034	CcSEcCtD
Perindopril—Eosinophilia—Doxorubicin—kidney cancer	6.93e-05	0.000337	CcSEcCtD
Perindopril—Nausea—Sorafenib—kidney cancer	6.92e-05	0.000336	CcSEcCtD
Perindopril—Pancreatitis—Doxorubicin—kidney cancer	6.86e-05	0.000334	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.86e-05	0.000333	CcSEcCtD
Perindopril—Malaise—Capecitabine—kidney cancer	6.82e-05	0.000332	CcSEcCtD
Perindopril—Angina pectoris—Doxorubicin—kidney cancer	6.82e-05	0.000332	CcSEcCtD
Perindopril—Insomnia—Paclitaxel—kidney cancer	6.81e-05	0.000331	CcSEcCtD
Perindopril—Vertigo—Capecitabine—kidney cancer	6.8e-05	0.000331	CcSEcCtD
Perindopril—Asthenia—Vincristine—kidney cancer	6.8e-05	0.000331	CcSEcCtD
Perindopril—Syncope—Capecitabine—kidney cancer	6.79e-05	0.00033	CcSEcCtD
Perindopril—Leukopenia—Capecitabine—kidney cancer	6.77e-05	0.000329	CcSEcCtD
Perindopril—Paraesthesia—Paclitaxel—kidney cancer	6.76e-05	0.000329	CcSEcCtD
Perindopril—Vomiting—Dactinomycin—kidney cancer	6.74e-05	0.000328	CcSEcCtD
Perindopril—Bronchitis—Doxorubicin—kidney cancer	6.73e-05	0.000327	CcSEcCtD
Perindopril—Dyspnoea—Paclitaxel—kidney cancer	6.71e-05	0.000326	CcSEcCtD
Perindopril—Somnolence—Paclitaxel—kidney cancer	6.69e-05	0.000325	CcSEcCtD
Perindopril—Palpitations—Capecitabine—kidney cancer	6.69e-05	0.000325	CcSEcCtD
Perindopril—Rash—Dactinomycin—kidney cancer	6.69e-05	0.000325	CcSEcCtD
Perindopril—Nausea—Sunitinib—kidney cancer	6.65e-05	0.000324	CcSEcCtD
Perindopril—Loss of consciousness—Capecitabine—kidney cancer	6.65e-05	0.000323	CcSEcCtD
Perindopril—Pancytopenia—Doxorubicin—kidney cancer	6.65e-05	0.000323	CcSEcCtD
Perindopril—Dyspepsia—Paclitaxel—kidney cancer	6.63e-05	0.000322	CcSEcCtD
Perindopril—Cough—Capecitabine—kidney cancer	6.6e-05	0.000321	CcSEcCtD
Perindopril—Neutropenia—Doxorubicin—kidney cancer	6.55e-05	0.000318	CcSEcCtD
Perindopril—Decreased appetite—Paclitaxel—kidney cancer	6.54e-05	0.000318	CcSEcCtD
Perindopril—Hypertension—Capecitabine—kidney cancer	6.53e-05	0.000318	CcSEcCtD
Perindopril—Upper respiratory tract infection—Doxorubicin—kidney cancer	6.51e-05	0.000316	CcSEcCtD
Perindopril—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.5e-05	0.000316	CcSEcCtD
Perindopril—Fatigue—Paclitaxel—kidney cancer	6.49e-05	0.000315	CcSEcCtD
Perindopril—Diarrhoea—Vincristine—kidney cancer	6.48e-05	0.000315	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—kidney cancer	6.47e-05	0.000314	CcSEcCtD
Perindopril—Asthenia—Gemcitabine—kidney cancer	6.45e-05	0.000314	CcSEcCtD
Perindopril—Arthralgia—Capecitabine—kidney cancer	6.44e-05	0.000313	CcSEcCtD
Perindopril—Chest pain—Capecitabine—kidney cancer	6.44e-05	0.000313	CcSEcCtD
Perindopril—Myalgia—Capecitabine—kidney cancer	6.44e-05	0.000313	CcSEcCtD
Perindopril—Constipation—Paclitaxel—kidney cancer	6.44e-05	0.000313	CcSEcCtD
Perindopril—Pain—Paclitaxel—kidney cancer	6.44e-05	0.000313	CcSEcCtD
Perindopril—BCHE—Phospholipid metabolism—ACHE—kidney cancer	6.43e-05	0.00595	CbGpPWpGaD
Perindopril—Anxiety—Capecitabine—kidney cancer	6.42e-05	0.000312	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.4e-05	0.000311	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—kidney cancer	6.39e-05	0.000311	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	6.39e-05	0.00592	CbGpPWpGaD
Perindopril—Discomfort—Capecitabine—kidney cancer	6.37e-05	0.000309	CcSEcCtD
Perindopril—Pruritus—Gemcitabine—kidney cancer	6.36e-05	0.000309	CcSEcCtD
Perindopril—Dry mouth—Capecitabine—kidney cancer	6.3e-05	0.000306	CcSEcCtD
Perindopril—Nausea—Dactinomycin—kidney cancer	6.3e-05	0.000306	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—kidney cancer	6.28e-05	0.000305	CcSEcCtD
Perindopril—Dizziness—Vincristine—kidney cancer	6.27e-05	0.000305	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—kidney cancer	6.24e-05	0.000303	CcSEcCtD
Perindopril—Confusional state—Capecitabine—kidney cancer	6.23e-05	0.000303	CcSEcCtD
Perindopril—Feeling abnormal—Paclitaxel—kidney cancer	6.2e-05	0.000302	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.19e-05	0.000301	CcSEcCtD
Perindopril—Oedema—Capecitabine—kidney cancer	6.18e-05	0.0003	CcSEcCtD
Perindopril—Gastrointestinal pain—Paclitaxel—kidney cancer	6.15e-05	0.000299	CcSEcCtD
Perindopril—Diarrhoea—Gemcitabine—kidney cancer	6.15e-05	0.000299	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—kidney cancer	6.14e-05	0.000298	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—kidney cancer	6.08e-05	0.000296	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—kidney cancer	6.08e-05	0.000296	CcSEcCtD
Perindopril—Shock—Capecitabine—kidney cancer	6.08e-05	0.000295	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—kidney cancer	6.07e-05	0.000295	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—kidney cancer	6.07e-05	0.000295	CcSEcCtD
Perindopril—Nervous system disorder—Capecitabine—kidney cancer	6.06e-05	0.000294	CcSEcCtD
Perindopril—Thrombocytopenia—Capecitabine—kidney cancer	6.05e-05	0.000294	CcSEcCtD
Perindopril—Tachycardia—Capecitabine—kidney cancer	6.03e-05	0.000293	CcSEcCtD
Perindopril—Vomiting—Vincristine—kidney cancer	6.03e-05	0.000293	CcSEcCtD
Perindopril—Skin disorder—Capecitabine—kidney cancer	6e-05	0.000292	CcSEcCtD
Perindopril—Sweating—Doxorubicin—kidney cancer	5.98e-05	0.000291	CcSEcCtD
Perindopril—Urticaria—Paclitaxel—kidney cancer	5.98e-05	0.000291	CcSEcCtD
Perindopril—Rash—Vincristine—kidney cancer	5.97e-05	0.00029	CcSEcCtD
Perindopril—Hyperhidrosis—Capecitabine—kidney cancer	5.97e-05	0.00029	CcSEcCtD
Perindopril—Dermatitis—Vincristine—kidney cancer	5.97e-05	0.00029	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—kidney cancer	5.95e-05	0.000289	CcSEcCtD
Perindopril—Abdominal pain—Paclitaxel—kidney cancer	5.95e-05	0.000289	CcSEcCtD
Perindopril—Body temperature increased—Paclitaxel—kidney cancer	5.95e-05	0.000289	CcSEcCtD
Perindopril—Headache—Vincristine—kidney cancer	5.94e-05	0.000289	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—kidney cancer	5.9e-05	0.000287	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—kidney cancer	5.89e-05	0.000286	CcSEcCtD
Perindopril—Anorexia—Capecitabine—kidney cancer	5.89e-05	0.000286	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—kidney cancer	5.86e-05	0.000285	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—kidney cancer	5.83e-05	0.000283	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—MME—kidney cancer	5.81e-05	0.00538	CbGpPWpGaD
Perindopril—Hypotension—Capecitabine—kidney cancer	5.77e-05	0.000281	CcSEcCtD
Perindopril—Vomiting—Gemcitabine—kidney cancer	5.72e-05	0.000278	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—kidney cancer	5.71e-05	0.000277	CcSEcCtD
Perindopril—Rash—Gemcitabine—kidney cancer	5.67e-05	0.000276	CcSEcCtD
Perindopril—Dermatitis—Gemcitabine—kidney cancer	5.66e-05	0.000275	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—kidney cancer	5.63e-05	0.000274	CcSEcCtD
Perindopril—Headache—Gemcitabine—kidney cancer	5.63e-05	0.000274	CcSEcCtD
Perindopril—Nausea—Vincristine—kidney cancer	5.63e-05	0.000274	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.63e-05	0.000274	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—kidney cancer	5.62e-05	0.000273	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—kidney cancer	5.6e-05	0.000272	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—kidney cancer	5.6e-05	0.000272	CcSEcCtD
Perindopril—Insomnia—Capecitabine—kidney cancer	5.59e-05	0.000272	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—kidney cancer	5.56e-05	0.00027	CcSEcCtD
Perindopril—Paraesthesia—Capecitabine—kidney cancer	5.55e-05	0.00027	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—kidney cancer	5.53e-05	0.000269	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—kidney cancer	5.52e-05	0.000268	CcSEcCtD
Perindopril—Dyspnoea—Capecitabine—kidney cancer	5.51e-05	0.000268	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—kidney cancer	5.49e-05	0.000267	CcSEcCtD
Perindopril—Dyspepsia—Capecitabine—kidney cancer	5.44e-05	0.000264	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—RPL14—kidney cancer	5.4e-05	0.005	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—HSPD1—kidney cancer	5.4e-05	0.005	CbGpPWpGaD
Perindopril—Visual impairment—Doxorubicin—kidney cancer	5.4e-05	0.000263	CcSEcCtD
Perindopril—Asthenia—Paclitaxel—kidney cancer	5.4e-05	0.000263	CcSEcCtD
Perindopril—Decreased appetite—Capecitabine—kidney cancer	5.37e-05	0.000261	CcSEcCtD
Perindopril—Nausea—Gemcitabine—kidney cancer	5.34e-05	0.00026	CcSEcCtD
Perindopril—Gastrointestinal disorder—Capecitabine—kidney cancer	5.33e-05	0.000259	CcSEcCtD
Perindopril—Fatigue—Capecitabine—kidney cancer	5.33e-05	0.000259	CcSEcCtD
Perindopril—Pruritus—Paclitaxel—kidney cancer	5.33e-05	0.000259	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—kidney cancer	5.3e-05	0.000258	CcSEcCtD
Perindopril—Pain—Capecitabine—kidney cancer	5.28e-05	0.000257	CcSEcCtD
Perindopril—Constipation—Capecitabine—kidney cancer	5.28e-05	0.000257	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—kidney cancer	5.24e-05	0.000255	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—kidney cancer	5.23e-05	0.000254	CcSEcCtD
Perindopril—Flushing—Doxorubicin—kidney cancer	5.2e-05	0.000253	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—kidney cancer	5.2e-05	0.000253	CcSEcCtD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	5.18e-05	0.0048	CbGpPWpGaD
Perindopril—Diarrhoea—Paclitaxel—kidney cancer	5.15e-05	0.00025	CcSEcCtD
Perindopril—Feeling abnormal—Capecitabine—kidney cancer	5.09e-05	0.000247	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—kidney cancer	5.08e-05	0.000247	CcSEcCtD
Perindopril—Gastrointestinal pain—Capecitabine—kidney cancer	5.05e-05	0.000246	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—kidney cancer	5.05e-05	0.000246	CcSEcCtD
Perindopril—Chills—Doxorubicin—kidney cancer	5.03e-05	0.000244	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—kidney cancer	5.01e-05	0.000243	CcSEcCtD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	5e-05	0.00463	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.99e-05	0.00462	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.99e-05	0.00462	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.99e-05	0.00462	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL13—kidney cancer	4.99e-05	0.00462	CbGpPWpGaD
Perindopril—Dizziness—Paclitaxel—kidney cancer	4.98e-05	0.000242	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—kidney cancer	4.95e-05	0.000241	CcSEcCtD
Perindopril—BCHE—Neuronal System—KCNMA1—kidney cancer	4.95e-05	0.00458	CbGpPWpGaD
Perindopril—Mental disorder—Doxorubicin—kidney cancer	4.91e-05	0.000239	CcSEcCtD
Perindopril—Urticaria—Capecitabine—kidney cancer	4.91e-05	0.000239	CcSEcCtD
Perindopril—Abdominal pain—Capecitabine—kidney cancer	4.88e-05	0.000237	CcSEcCtD
Perindopril—Body temperature increased—Capecitabine—kidney cancer	4.88e-05	0.000237	CcSEcCtD
Perindopril—Erythema—Doxorubicin—kidney cancer	4.88e-05	0.000237	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—kidney cancer	4.88e-05	0.000237	CcSEcCtD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	4.81e-05	0.00445	CbGpPWpGaD
Perindopril—Flatulence—Doxorubicin—kidney cancer	4.81e-05	0.000234	CcSEcCtD
Perindopril—Tension—Doxorubicin—kidney cancer	4.79e-05	0.000233	CcSEcCtD
Perindopril—Vomiting—Paclitaxel—kidney cancer	4.79e-05	0.000233	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—kidney cancer	4.78e-05	0.000232	CcSEcCtD
Perindopril—BCHE—Transmission across Chemical Synapses—ACHE—kidney cancer	4.78e-05	0.00442	CbGpPWpGaD
Perindopril—Rash—Paclitaxel—kidney cancer	4.75e-05	0.000231	CcSEcCtD
Perindopril—Dermatitis—Paclitaxel—kidney cancer	4.74e-05	0.00023	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—kidney cancer	4.74e-05	0.00023	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—EIF5B—kidney cancer	4.72e-05	0.00437	CbGpPWpGaD
Perindopril—Back pain—Doxorubicin—kidney cancer	4.72e-05	0.000229	CcSEcCtD
Perindopril—Headache—Paclitaxel—kidney cancer	4.72e-05	0.000229	CcSEcCtD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	4.7e-05	0.00436	CbGpPWpGaD
Perindopril—Muscle spasms—Doxorubicin—kidney cancer	4.69e-05	0.000228	CcSEcCtD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	4.64e-05	0.0043	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	4.63e-05	0.00429	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	4.63e-05	0.00429	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	4.63e-05	0.00429	CbGpPWpGaD
Perindopril—Ill-defined disorder—Doxorubicin—kidney cancer	4.53e-05	0.00022	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—kidney cancer	4.51e-05	0.000219	CcSEcCtD
Perindopril—Agitation—Doxorubicin—kidney cancer	4.48e-05	0.000218	CcSEcCtD
Perindopril—Nausea—Paclitaxel—kidney cancer	4.47e-05	0.000217	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—ACHE—kidney cancer	4.45e-05	0.00413	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.45e-05	0.00413	CbGpPWpGaD
Perindopril—Asthenia—Capecitabine—kidney cancer	4.43e-05	0.000215	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—EIF4EBP1—kidney cancer	4.4e-05	0.00408	CbGpPWpGaD
Perindopril—Malaise—Doxorubicin—kidney cancer	4.4e-05	0.000214	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—kidney cancer	4.38e-05	0.000213	CcSEcCtD
Perindopril—Syncope—Doxorubicin—kidney cancer	4.37e-05	0.000213	CcSEcCtD
Perindopril—Pruritus—Capecitabine—kidney cancer	4.37e-05	0.000212	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—kidney cancer	4.37e-05	0.000212	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—kidney cancer	4.31e-05	0.00021	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—kidney cancer	4.29e-05	0.000208	CcSEcCtD
Perindopril—BCHE—Peptide hormone metabolism—POMC—kidney cancer	4.26e-05	0.00395	CbGpPWpGaD
Perindopril—Cough—Doxorubicin—kidney cancer	4.26e-05	0.000207	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—PAX6—kidney cancer	4.24e-05	0.00393	CbGpPWpGaD
Perindopril—Diarrhoea—Capecitabine—kidney cancer	4.23e-05	0.000205	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—CTSD—kidney cancer	4.22e-05	0.00391	CbGpPWpGaD
Perindopril—Hypertension—Doxorubicin—kidney cancer	4.21e-05	0.000205	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—CUL7—kidney cancer	4.21e-05	0.0039	CbGpPWpGaD
Perindopril—Myalgia—Doxorubicin—kidney cancer	4.15e-05	0.000202	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—kidney cancer	4.15e-05	0.000202	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—kidney cancer	4.15e-05	0.000202	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—kidney cancer	4.14e-05	0.000201	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.12e-05	0.000201	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—kidney cancer	4.1e-05	0.000199	CcSEcCtD
Perindopril—Dizziness—Capecitabine—kidney cancer	4.08e-05	0.000199	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—kidney cancer	4.06e-05	0.000197	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—kidney cancer	4.01e-05	0.000195	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—HSPA9—kidney cancer	4.01e-05	0.00372	CbGpPWpGaD
Perindopril—Anaphylactic shock—Doxorubicin—kidney cancer	3.98e-05	0.000194	CcSEcCtD
Perindopril—Oedema—Doxorubicin—kidney cancer	3.98e-05	0.000194	CcSEcCtD
Perindopril—Vomiting—Capecitabine—kidney cancer	3.93e-05	0.000191	CcSEcCtD
Perindopril—Shock—Doxorubicin—kidney cancer	3.92e-05	0.00019	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—kidney cancer	3.9e-05	0.00019	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—kidney cancer	3.9e-05	0.00019	CcSEcCtD
Perindopril—Rash—Capecitabine—kidney cancer	3.89e-05	0.000189	CcSEcCtD
Perindopril—Dermatitis—Capecitabine—kidney cancer	3.89e-05	0.000189	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—kidney cancer	3.89e-05	0.000189	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—BCHE—kidney cancer	3.88e-05	0.0036	CbGpPWpGaD
Perindopril—Headache—Capecitabine—kidney cancer	3.87e-05	0.000188	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—kidney cancer	3.87e-05	0.000188	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—kidney cancer	3.85e-05	0.000187	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—kidney cancer	3.8e-05	0.000185	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—kidney cancer	3.72e-05	0.000181	CcSEcCtD
Perindopril—Nausea—Capecitabine—kidney cancer	3.67e-05	0.000178	CcSEcCtD
Perindopril—BCHE—Neuronal System—ACHE—kidney cancer	3.66e-05	0.00339	CbGpPWpGaD
Perindopril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.63e-05	0.000176	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—kidney cancer	3.6e-05	0.000175	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—kidney cancer	3.58e-05	0.000174	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—kidney cancer	3.55e-05	0.000173	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—kidney cancer	3.54e-05	0.000172	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—kidney cancer	3.5e-05	0.00017	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—kidney cancer	3.46e-05	0.000168	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.44e-05	0.000167	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—kidney cancer	3.43e-05	0.000167	CcSEcCtD
Perindopril—Pain—Doxorubicin—kidney cancer	3.4e-05	0.000166	CcSEcCtD
Perindopril—Constipation—Doxorubicin—kidney cancer	3.4e-05	0.000166	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	3.39e-05	0.00315	CbGpPWpGaD
Perindopril—Feeling abnormal—Doxorubicin—kidney cancer	3.28e-05	0.00016	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—MUC4—kidney cancer	3.27e-05	0.00303	CbGpPWpGaD
Perindopril—Gastrointestinal pain—Doxorubicin—kidney cancer	3.26e-05	0.000158	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—kidney cancer	3.16e-05	0.000154	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—kidney cancer	3.15e-05	0.000153	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—kidney cancer	3.15e-05	0.000153	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—ST3GAL2—kidney cancer	3.11e-05	0.00288	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—CTNNB1—kidney cancer	3.04e-05	0.00282	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—EEF2—kidney cancer	3.04e-05	0.00282	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	3.04e-05	0.00281	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGF2—kidney cancer	3e-05	0.00278	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	2.93e-05	0.00272	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	2.93e-05	0.00272	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ACY1—kidney cancer	2.86e-05	0.00265	CbGpPWpGaD
Perindopril—Asthenia—Doxorubicin—kidney cancer	2.86e-05	0.000139	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—kidney cancer	2.82e-05	0.000137	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	2.78e-05	0.00257	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	2.73e-05	0.00253	CbGpPWpGaD
Perindopril—Diarrhoea—Doxorubicin—kidney cancer	2.72e-05	0.000132	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—kidney cancer	2.63e-05	0.000128	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.63e-05	0.00244	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.54e-05	0.00236	CbGpPWpGaD
Perindopril—Vomiting—Doxorubicin—kidney cancer	2.53e-05	0.000123	CcSEcCtD
Perindopril—Rash—Doxorubicin—kidney cancer	2.51e-05	0.000122	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—kidney cancer	2.51e-05	0.000122	CcSEcCtD
Perindopril—Headache—Doxorubicin—kidney cancer	2.49e-05	0.000121	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.44e-05	0.00226	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	2.44e-05	0.00226	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.44e-05	0.00226	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PDHB—kidney cancer	2.43e-05	0.00225	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	2.42e-05	0.00224	CbGpPWpGaD
Perindopril—Nausea—Doxorubicin—kidney cancer	2.36e-05	0.000115	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.36e-05	0.00219	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MME—kidney cancer	2.33e-05	0.00216	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CCBL1—kidney cancer	2.29e-05	0.00212	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	2.22e-05	0.00206	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—RPL14—kidney cancer	2.17e-05	0.00201	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—HSPD1—kidney cancer	2.17e-05	0.00201	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	2.12e-05	0.00197	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.07e-05	0.00192	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PTEN—kidney cancer	2.01e-05	0.00186	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.01e-05	0.00186	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—POMC—kidney cancer	2.01e-05	0.00186	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.99e-05	0.00185	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	1.99e-05	0.00185	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GLIPR1—kidney cancer	1.98e-05	0.00184	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PPAT—kidney cancer	1.98e-05	0.00184	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.96e-05	0.00181	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.94e-05	0.0018	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.87e-05	0.00173	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.87e-05	0.00173	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.86e-05	0.00173	CbGpPWpGaD
Perindopril—BCHE—Metabolism—FH—kidney cancer	1.84e-05	0.00171	CbGpPWpGaD
Perindopril—BCHE—Metabolism—APRT—kidney cancer	1.84e-05	0.00171	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.83e-05	0.0017	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ACHE—kidney cancer	1.79e-05	0.00166	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	1.77e-05	0.00164	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	1.77e-05	0.00164	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GPC3—kidney cancer	1.73e-05	0.00161	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—PAX6—kidney cancer	1.7e-05	0.00158	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CTSD—kidney cancer	1.69e-05	0.00157	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CA2—kidney cancer	1.69e-05	0.00156	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALAD—kidney cancer	1.64e-05	0.00152	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.64e-05	0.00152	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2—kidney cancer	1.63e-05	0.00151	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—BRAF—kidney cancer	1.63e-05	0.00151	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.62e-05	0.0015	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ST3GAL2—kidney cancer	1.6e-05	0.00149	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.6e-05	0.00148	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALDH1A1—kidney cancer	1.57e-05	0.00145	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.57e-05	0.00145	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.57e-05	0.00145	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.57e-05	0.00145	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC5A3—kidney cancer	1.5e-05	0.00139	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PGK1—kidney cancer	1.5e-05	0.00139	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LDHB—kidney cancer	1.47e-05	0.00137	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CTNNB1—kidney cancer	1.43e-05	0.00133	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	1.42e-05	0.00132	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ACY1—kidney cancer	1.4e-05	0.00129	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.39e-05	0.00128	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—RAF1—kidney cancer	1.36e-05	0.00126	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CA9—kidney cancer	1.28e-05	0.00118	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.25e-05	0.00116	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.22e-05	0.00113	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGF2—kidney cancer	1.21e-05	0.00112	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PDHB—kidney cancer	1.19e-05	0.0011	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.14e-05	0.00106	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.14e-05	0.00105	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CCBL1—kidney cancer	1.12e-05	0.00103	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CRABP1—kidney cancer	1.09e-05	0.00101	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.05e-05	0.000976	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ITPR2—kidney cancer	1.01e-05	0.000936	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PPAT—kidney cancer	9.68e-06	0.000897	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GLIPR1—kidney cancer	9.68e-06	0.000897	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—MAPK1—kidney cancer	9.32e-06	0.000863	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.31e-06	0.000863	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ACHE—kidney cancer	9.21e-06	0.000854	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTT1—kidney cancer	9.21e-06	0.000854	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—APRT—kidney cancer	9e-06	0.000834	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—FH—kidney cancer	9e-06	0.000834	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	8.97e-06	0.000831	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	8.88e-06	0.000822	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SCARB1—kidney cancer	8.72e-06	0.000808	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	8.68e-06	0.000804	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTGS1—kidney cancer	8.63e-06	0.0008	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PSMD7—kidney cancer	8.47e-06	0.000784	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GPC3—kidney cancer	8.46e-06	0.000784	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.26e-06	0.000765	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CA2—kidney cancer	8.23e-06	0.000762	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	8.22e-06	0.000762	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—POMC—kidney cancer	8.05e-06	0.000746	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALAD—kidney cancer	8.02e-06	0.000743	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.98e-06	0.000739	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC5A5—kidney cancer	7.93e-06	0.000735	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	7.84e-06	0.000727	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ST3GAL2—kidney cancer	7.83e-06	0.000725	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	7.83e-06	0.000725	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	7.77e-06	0.00072	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC2A1—kidney cancer	7.66e-06	0.000709	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALDH1A1—kidney cancer	7.65e-06	0.000709	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	7.57e-06	0.000701	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.43e-06	0.000688	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PGK1—kidney cancer	7.33e-06	0.00068	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC5A3—kidney cancer	7.33e-06	0.00068	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LDHB—kidney cancer	7.19e-06	0.000666	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	6.84e-06	0.000634	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.48e-06	0.0006	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.47e-06	0.000599	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTP1—kidney cancer	6.39e-06	0.000592	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	6.29e-06	0.000583	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CA9—kidney cancer	6.24e-06	0.000578	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	6.15e-06	0.00057	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCB1—kidney cancer	6.05e-06	0.00056	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTM1—kidney cancer	5.87e-06	0.000544	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.81e-06	0.000539	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	5.74e-06	0.000532	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP1A1—kidney cancer	5.56e-06	0.000515	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.34e-06	0.000495	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CRABP1—kidney cancer	5.3e-06	0.000491	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.17e-06	0.000479	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ITPR2—kidney cancer	4.93e-06	0.000457	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.57e-06	0.000423	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ACHE—kidney cancer	4.5e-06	0.000416	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTT1—kidney cancer	4.5e-06	0.000416	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SCARB1—kidney cancer	4.26e-06	0.000394	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTGS1—kidney cancer	4.21e-06	0.00039	CbGpPWpGaD
Perindopril—BCHE—Metabolism—POMC—kidney cancer	4.15e-06	0.000384	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PSMD7—kidney cancer	4.13e-06	0.000383	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—BCHE—kidney cancer	3.92e-06	0.000363	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC5A5—kidney cancer	3.87e-06	0.000358	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC2A1—kidney cancer	3.74e-06	0.000346	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.56e-06	0.00033	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTGS2—kidney cancer	3.31e-06	0.000307	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTP1—kidney cancer	3.12e-06	0.000289	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTEN—kidney cancer	2.89e-06	0.000267	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTM1—kidney cancer	2.86e-06	0.000265	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP1A1—kidney cancer	2.71e-06	0.000251	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CA—kidney cancer	2.04e-06	0.000189	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—POMC—kidney cancer	2.02e-06	0.000188	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTGS2—kidney cancer	1.61e-06	0.00015	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTEN—kidney cancer	1.41e-06	0.00013	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CA—kidney cancer	9.93e-07	9.2e-05	CbGpPWpGaD
